BCD Bioscience is a startup based in the United States, most recent round Series A, 1 tracked investor.
BCD Bioscience is a startup based in the United States. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
BCD Bioscience develops proprietary technology to create precision oligosaccharides from natural fibers that act as prebiotics and immunomodulators for pharmaceutical and food ingredient applications.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.